Grifols(OTC) GIFLF

Current Price$10.25

Market Cap$6.98B

Since IPO (2007)-57%

5 Year-56%

1 Year-25%

1 Month-1%

Grifols last closing stock price
Metric	Price	Date
Last close	USD 10.25	2026-07-17

Grifols stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-0.92%	USD 10.35	2026-07-08
1 month	-1.03%	USD 10.36	2026-06-15
3 month	-2.15%	USD 10.48	2026-04-06
Year to date	-11.29%	USD 11.55	2025-11-21
1 year	-25.18%	USD 13.70	2025-07-16
3 year	-11.23%	USD 11.55	2023-06-13
5 year	-56.17%	USD 23.39	2021-07-15
Since inception	-57.24%	USD 23.97	2007-10-19

Grifols Financials at a Glance

Market Cap

$6.98B

Revenue (TTM)

€7.44B

Net Income (TTM)

€415.41M

EPS (TTM)

$0.71

P/E Ratio

14.50

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$10.25

Volume

225

Open

$10.25

Price

$10.25

Volume

225

Open

$10.25

Previous Close

$10.25

Daily Range

$10.25 - $10.25

52-Week Range

$10.13 - $13.90

Estimated Earnings Date

Jul 28, 2026

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$10.25

Volume

225

Open

$10.25

Previous Close

$10.25

Daily Range

$10.25 - $10.25

52-Week Range

$10.13 - $13.90

Estimated Earnings Date

Jul 28, 2026

GIFLF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grifols

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Industry

Biotechnology

Sector

Health Care

Employees

25,258

CEO

Nacho Abia Buenache, MBA

Website

www.grifols.com

Headquarters

Barcelona, CT 08174, ES

GIFLF Financials

Key Financial Metrics (TTM)

Gross Margin

37.68%

Operating Margin

16.89%

Net Income Margin

5.58%

Return on Equity

7.88%

Return on Capital

8.29%

Return on Assets

2.07%

Earnings Yield

6.90%

Dividend Yield

0.00%

Payout Ratio

30.83%

Stock Overview

Market Cap

$6.98B

Shares Outstanding

680.58M

Volume

225

Avg. Volume

517.307

Financials (TTM)

Gross Profit

€2.80B

Operating Income

€1.26B

EBITDA

€1.43B

Operating Cash Flow

€1.02B

Capital Expenditure

-€268.02M

Free Cash Flow

€753.77M

Cash & ST Invst.

€758.00M

Total Debt

€9.71B

Grifols Performance Analysis

Grifols annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 6,373,073,574	9.3%
2023	2023-12-31	EUR 7,126,689,189	11.8%
2024	2024-12-31	EUR 7,801,566,940	9.5%
2025	2025-12-31	EUR 8,491,420,500	8.8%

Grifols sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	5.9%
Q3	2025-09-30	-1.4%
Q4	2025-12-31	6.2%
Q1	2026-03-31	-13.9%

Grifols annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 0.32	-1.9%
2023	2023-12-31	EUR 0.07	-79.1%
2024	2024-12-31	EUR 0.25	270.2%
2025	2025-12-31	EUR 0.67	167.2%

Grifols sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	93.6%
Q3	2025-09-30	11.8%
Q4	2025-12-31	-26.3%
Q1	2026-03-31	-28.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

€1.71B

-4.4%

Gross Profit

€622.35M

-11.7%

Gross Margin

36.47%

N/A

Market Cap

$6.98B

N/A

Market Cap/Employee

$292.70K

N/A

Employees

23,833

N/A

Net Income

€73.28M

+22.7%

EBITDA

€354.34M

-12.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

€758.00M

-24.6%

Total Debt

€9.71B

-3.4%

Accounts Receivable

€961.64M

-7.5%

Inventory

€3.47B

-1.5%

Long Term Debt

€9.11B

-2.9%

Short Term Debt

€591.24M

-10.1%

Return on Assets

2.07%

N/A

Return on Invested Capital

7.00%

N/A

Free Cash Flow

€58.22M

-32.6%

Operating Cash Flow

€110.42M

-18.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MTHRYM3, Inc.

MTHRYM3, Inc.$5.50+0.73%

ESALFEisai Co., Ltd.

ESALFEisai Co., Ltd.$26.18+0.00%

KYKOFKyowa Kirin Co., Ltd.

KYKOFKyowa Kirin Co., Ltd.$14.43+0.00%

ESAIYEisai Co., Ltd.

ESAIYEisai Co., Ltd.$7.10+2.31%

BDUUFBangkok Dusit Medical Services Public Company Limited

BDUUFBangkok Dusit Medical Services Public Company Limited$0.64+0.00%

RCDTFRecordati S.p.A.

RCDTFRecordati S.p.A.$58.00+0.00%

CSPCYCSPC Pharmaceutical Group Limited

CSPCYCSPC Pharmaceutical Group Limited$4.31+1.41%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

TAT&T

TAT&T$24.13+0.05%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

Questions About GIFLF

What is the current price of Grifols?

Grifols is trading at $10.25 per share.

What is the 52-week range for Grifols?

Over the past 52 weeks, Grifols has traded between $10.13 and $13.90.

How much debt does Grifols have?

As of the most recent reporting period, Grifols reported total debt of €11.14B.

How much cash does Grifols have on hand?

Grifols reported €808.84M in cash and cash equivalents in its most recent financial results.

What is Grifols’s dividend yield?

Grifols does not currently have a dividend yield.

Grifols(OTC) GIFLF

Grifols Financials at a Glance

GIFLF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Grifols

GIFLF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Grifols Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GIFLF

What is the current price of Grifols?

What is the 52-week range for Grifols?

How much debt does Grifols have?

How much cash does Grifols have on hand?

What is Grifols’s dividend yield?

Premium Investing Services